Private Trust Company’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $129K | Sell |
3,032
-1,297
| -30% | -$70.4K | 0.01% | 977 |
|
|
2026
Q1 | $272K | Sell |
4,329
-16
| -0.4% | -$1.28K | 0.02% | 658 |
|
|
2025
Q4 | $414K | Buy |
4,345
+359
| +9% | +$35.2K | 0.04% | 504 |
|
|
2025
Q3 | $389K | Buy |
3,986
+268
| +7% | +$27.8K | 0.03% | 506 |
|
|
2025
Q2 | $399K | Buy |
3,718
+799
| +27% | +$80.8K | 0.04% | 470 |
|
|
2025
Q1 | $294K | Buy |
2,919
+299
| +11% | +$30.1K | 0.03% | 563 |
|
|
2024
Q4 | $234K | Sell |
2,620
-3,526
| -57% | -$310K | 0.02% | 634 |
|
|
2024
Q3 | $515K | Sell |
6,146
-154
| -2% | -$12.1K | 0.05% | 377 |
|
|
2024
Q2 | $485K | Buy |
6,300
+585
| +10% | +$42.8K | 0.05% | 376 |
|
|
2024
Q1 | $391K | Buy |
5,715
+523
| +10% | +$33.6K | 0.04% | 432 |
|
|
2023
Q4 | $300K | Buy |
5,192
+60
| +1% | +$3.2K | 0.04% | 485 |
|
|
2023
Q3 | $271K | Buy |
5,132
+4,275
| +499% | +$224K | 0.04% | 483 |
|
|
2023
Q2 | $46.4K | Sell |
857
-245
| -22% | -$12.8K | 0.01% | 1058 |
|
|
2023
Q1 | $55.1K | Sell |
1,102
-5
| -0.5% | -$236 | 0.01% | 964 |
|
|
2022
Q4 | $51K | Sell |
1,107
-46
| -4% | -$1.99K | 0.01% | 949 |
|
|
2022
Q3 | $45K | Sell |
1,153
-15
| -1% | -$602 | 0.01% | 915 |
|
|
2022
Q2 | $44K | Sell |
1,168
-38,912
| -97% | -$1.58M | 0.01% | 974 |
|
|
2022
Q1 | $1.77M | Sell |
40,080
-9,700
| -19% | -$420K | 0.28% | 97 |
|
|
2021
Q4 | $2.12M | Sell |
49,780
-340
| -0.7% | -$14.3K | 0.29% | 97 |
|
|
2021
Q3 | $2.17M | Sell |
50,120
-405
| -0.8% | -$17.9K | 0.32% | 94 |
|
|
2021
Q2 | $2.16M | Buy |
50,525
+1,357
| +3% | +$57.1K | 0.33% | 92 |
|
|
2021
Q1 | $1.9M | Sell |
49,168
-197
| -0.4% | -$7.46K | 0.31% | 91 |
|
|
2020
Q4 | $1.77M | Buy |
49,365
+2,197
| +5% | +$79.2K | 0.3% | 92 |
|
|
2020
Q3 | $1.8M | Sell |
47,168
-2,697
| -5% | -$104K | 0.35% | 77 |
|
|
2020
Q2 | $1.76M | Buy |
49,865
+4,781
| +11% | +$172K | 0.37% | 73 |
|
|
2020
Q1 | $1.47M | Sell |
45,084
-1,382
| -3% | -$54K | 0.38% | 74 |
|
|
2019
Q4 | $2.1M | Sell |
46,466
-44
| -0.1% | -$1.84K | 0.39% | 71 |
|
|
2019
Q3 | $1.89M | Buy |
46,510
+118
| +0.3% | +$5K | 0.37% | 71 |
|
|
2019
Q2 | $1.99M | Buy |
46,392
+7,129
| +18% | +$274K | 0.4% | 67 |
|
|
2019
Q1 | $1.51M | Sell |
39,263
-4,733
| -11% | -$181K | 0.31% | 88 |
|
|
2018
Q4 | $1.55M | Sell |
43,996
-6,163
| -12% | -$224K | 0.37% | 71 |
|
|
2018
Q3 | $1.93M | Buy |
50,159
+340
| +0.7% | +$11.9K | 0.39% | 67 |
|
|
2018
Q2 | $1.63M | Sell |
49,819
-4,709
| -9% | -$142K | 0.35% | 75 |
|
|
2018
Q1 | $1.49M | Sell |
54,528
-114
| -0.2% | -$3.1K | 0.33% | 80 |
|
|
2017
Q4 | $1.35M | Buy |
54,642
+6,905
| +14% | +$190K | 0.29% | 85 |
|
|
2017
Q3 | $1.39M | Sell |
47,737
-141
| -0.3% | -$3.89K | 0.3% | 83 |
|
|
2017
Q2 | $1.33M | Sell |
47,878
-3
| -0% | -$80 | 0.29% | 86 |
|
|
2017
Q1 | $1.19M | Sell |
47,881
-4,828
| -9% | -$117K | 0.28% | 93 |
|
|
2016
Q4 | $1.14M | Buy |
52,709
+28,163
| +115% | +$615K | 0.27% | 93 |
|
|
2016
Q3 | $584K | Buy |
24,546
+3,319
| +16% | +$79.2K | 0.14% | 173 |
|
|
2016
Q2 | $496K | Buy |
21,227
+843
| +4% | +$18.2K | 0.13% | 192 |
|
|
2016
Q1 | $383K | Buy |
+20,384
| New | +$358K | 0.1% | 227 |
|
|
2014
Q4 | – | Sell |
-3,000
| Closed | -$35K | – | 414 |
|
|
2014
Q3 | $35K | Hold |
3,000
| – | – | 0.01% | 654 |
|
|
2014
Q2 | $38K | Hold |
3,000
| – | – | 0.01% | 644 |
|
|
2014
Q1 | $41K | Sell |
3,000
-282
| -9% | -$3.7K | 0.02% | 536 |
|
|
2013
Q4 | $39K | Hold |
3,282
| – | – | 0.02% | 505 |
|
|
2013
Q3 | $39K | Hold |
3,282
| – | – | 0.02% | 477 |
|
|
2013
Q2 | $30K | Buy |
+3,282
| New | +$27.8K | 0.01% | 511 |
|
Other funds holding BSX
Private Trust Company's BSX Position: Q2 2026 in Review
Private Trust Company reduced its Boston Scientific (BSX) stake by 30% in Q2 2026, selling an estimated $70.4K and leaving 3,032 shares worth $129K. The position accounts for 0.01% of the portfolio, ranked #977.
Private Trust Company first reported a position in BSX in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.17M in Q3 2021. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Private Trust Company held 3,032 shares of Boston Scientific worth $129K as of Q2 2026.
- Private Trust Company sold 1,297 Boston Scientific shares in Q2 2026, an estimated $70.4K.
- Boston Scientific made up 0.01% of Private Trust Company's portfolio in Q2 2026, its #977 holding.
- Private Trust Company first reported a position in Boston Scientific in Q2 2013 and has held it in 48 quarters since.
- Private Trust Company's Boston Scientific position peaked at $2.17M in Q3 2021.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.